The Bcl-xL and Bax-α control points: Modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation

Biochemistry and Cell Biology

Volumn 75, Issue 4, 1997, Pages 301-314

  Schmitt, E ^a   Sane A T ^a   Steyaert, A ^a   Cimoli, G ^a,b   Bertrand, R ^a  

^a Institut du Cancer de Montreal   (Canada)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Apoptosis; Bax ; Bcl xL; Caspase; DNA topoisomerase inhibitors; Serine protease

Indexed keywords

ANTINEOPLASTIC AGENT; BAX PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; CYSTEINE PROTEINASE; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; SERINE PROTEINASE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE;

ANIMAL; APOPTOSIS; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CYSTEINE ENDOPEPTIDASES; ENZYME ACTIVATION; HUMANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SERINE ENDOPEPTIDASES; TOSYLPHENYLALANYL CHLOROMETHYL KETONE;

EID: 0031309406     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/bcb-75-4-301     Document Type: Article

References (15)

1. Adjei, P.N., Kaufmann, S.H., Leung, W.Y., Mao, F., and Gores, G.J. 1996. Selective induction of apoptosis in Hep 3b cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32. J. Clin. Invest. 98: 2588-2596.
2. Alnemri, E.S., Fernandes-Alnemri, T., and Litwack, G. 1995. Cloning and expression of four novel isoforms of human interleukin-1 beta converting enzyme with different apoptotic activities. J. Biol. Chem. 270: 4312-4317.
3. Apte, S.S., Mattei, M.G., and Olsen, B.R. 1995. Mapping of the human Bax gene to chromosome 19q13.3-q13.4 and isolation of a novel alternatively spliced transcript, Baxd. Genomics, 26: 592-594.
4. Bargou, R.C., Daniel, P.T., Mapara, M.Y., Bommert, K., Wagener, C., Kallinich, B., Royer, H.D., and Dorken, B. 1995. Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Int. J. Cancer, 60: 854-859.
5. Barry, M.A., Behnke, C.A., and Eastman, A. 1990. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol. 40: 2353-2362.
6. Bernardi, P., Broekemeier, K.M., and Pfeiffer, D.R. 1994. Recent progress on regulation of the mitochondrial permeability transition pore; a cyslosporin-sensitive pore in the inner mitochondrial membrane. J. Bioenerg. Biomembr. 26: 509-517.
7. Bertrand, R., and Pommier, Y. 1995. Assessment of DNA damage in mammalian cells by DNA filter elution methodology. In Cell growth and apoptosis; a practical approach. Edited by G.P. Studzinski. IRL Press, New York. pp. 97-118.
8. Bertrand, R., Sarang, M., Jenkin, J., Kerrigan, D., and Pommier, Y. 1991. Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res. 51: 6280-6285.
9. Bertrand, R., O'Connor, P., Kerrigan, D., and Pommier, Y. 1992. Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human carcinoma, HT-29 cells. Eur. J. Cancer A, 28: 743-748.
10. Bertrand, R., Solary, E., Jenkins, J., and Pommier, Y. 1993. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors. Exp. Cell Res. 207: 388-397.
11. Bertrand, R., Solary, E., O'Connor, P., Kohn, K.W., and Pommier, Y. 1994. Induction of a common pathway of apoptosis by staurosporine. Exp. Cell Res. 211: 314-321.
12. Bertrand, R., Kohn, K., Solary, E., and Pommier, Y. 1995. Detection of apoptosis-associated DNA fragmentation using a rapid and quantitative filter elution assay. Drug Dev. Res. 34: 138-144.
13. Boise, L.H., Gonzalez-Garcia, M., Postema, C.E., Ding, L., Lindsten, T., Turka, L.A., Mao, X., Nunez, G., and Thompson, C.B. 1993. Bcl-x, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74: 597-608.
14. Boldin, M.P., Goncharov, T., Goltsev, Y.V., and Wallach, D. 1996. Involvement of mach, a novel Mort1/Fadd-interacting protease, in Fas/Apo-1- and Tnf receptor-induced cell death. Cell, 85: 803-815.
15. Boyd, J.M., Gallo, G.J., Elangovan, B., Houghton, A.B., Malstrom, S., Avery, B.J., Ebb, R.G., Subramanian, T., Chittenden, T., Lutz, R.J., and Chinnadurai, G. 1995. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene, 11: 1921-1928.